TABLE 1.

Demographics, laboratory and histopathological characteristics of patients with autoimmune hepatitis following COVID‐19 vaccination at University Malaya Medical Centre (UMMC)

Patient	Age (years)	Gender	Latency (Days)	ALP/AST at presentation (U/L)	ALP/ALT at presentation (U/L)	Bilirubin at presentation (μmol/L)	Antibodies	IgG (mg/dL)	Liver biopsy results
1	59	Female	12	189/962	189/1178	126	–	1740	Lympho‐plasma‐cellular portal infiltrates with no biliary features
2	63	Female	14	299/505	299/354	313	ANA	2030	Bridging fibrosis consistent with underlying PSC. Presence of interface and lobular hepatitis
3	72	Female	10	125/1452	125/2280	29	AMA	1940	Portal inflammatory cell infiltration comprises mostly of lymphocytes and plasma cells with foci of lobular inflammation and hepatocyte necrosis